These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34607601)

  • 1. Association of CaMK2A and MeCP2 signaling pathways with cognitive ability in adolescents.
    Lee LC; Su MT; Huang HY; Cho YC; Yeh TK; Chang CY
    Mol Brain; 2021 Oct; 14(1):152. PubMed ID: 34607601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability.
    Küry S; van Woerden GM; Besnard T; Proietti Onori M; Latypova X; Towne MC; Cho MT; Prescott TE; Ploeg MA; Sanders S; Stessman HAF; Pujol A; Distel B; Robak LA; Bernstein JA; Denommé-Pichon AS; Lesca G; Sellars EA; Berg J; Carré W; Busk ØL; van Bon BWM; Waugh JL; Deardorff M; Hoganson GE; Bosanko KB; Johnson DS; Dabir T; Holla ØL; Sarkar A; Tveten K; de Bellescize J; Braathen GJ; Terhal PA; Grange DK; van Haeringen A; Lam C; Mirzaa G; Burton J; Bhoj EJ; Douglas J; Santani AB; Nesbitt AI; Helbig KL; Andrews MV; Begtrup A; Tang S; van Gassen KLI; Juusola J; Foss K; Enns GM; Moog U; Hinderhofer K; Paramasivam N; Lincoln S; Kusako BH; Lindenbaum P; Charpentier E; Nowak CB; Cherot E; Simonet T; Ruivenkamp CAL; Hahn S; Brownstein CA; Xia F; Schmitt S; Deb W; Bonneau D; Nizon M; Quinquis D; Chelly J; Rudolf G; Sanlaville D; Parent P; Gilbert-Dussardier B; Toutain A; Sutton VR; Thies J; Peart-Vissers LELM; Boisseau P; Vincent M; Grabrucker AM; Dubourg C; ; Tan WH; Verbeek NE; Granzow M; Santen GWE; Shendure J; Isidor B; Pasquier L; Redon R; Yang Y; State MW; Kleefstra T; Cogné B; ; ; Petrovski S; Retterer K; Eichler EE; Rosenfeld JA; Agrawal PB; Bézieau S; Odent S; Elgersma Y; Mercier S
    Am J Hum Genet; 2017 Nov; 101(5):768-788. PubMed ID: 29100089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient mice.
    El-Khoury R; Panayotis N; Matagne V; Ghata A; Villard L; Roux JC
    PLoS One; 2014; 9(3):e92169. PubMed ID: 24667344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear calcium signaling controls methyl-CpG-binding protein 2 (MeCP2) phosphorylation on serine 421 following synaptic activity.
    Buchthal B; Lau D; Weiss U; Weislogel JM; Bading H
    J Biol Chem; 2012 Sep; 287(37):30967-74. PubMed ID: 22822052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a CAMK2A genetic variant with logical memory performance and hippocampal volume in the elderly.
    Rhein C; Mühle C; Lenz B; Richter-Schmidinger T; Kogias G; Boix F; Lourdusamy A; Dörfler A; Peters O; Ramirez A; Jessen F; Maier W; Hüll M; Frölich L; Teipel S; Wiltfang J; Kornhuber J; Müller CP
    Brain Res Bull; 2020 Aug; 161():13-20. PubMed ID: 32418901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of alcohol consumption in humans; the role of metabotropic glutamate receptors and downstream signaling pathways.
    Meyers JL; Salling MC; Almli LM; Ratanatharathorn A; Uddin M; Galea S; Wildman DE; Aiello AE; Bradley B; Ressler K; Koenen KC
    Transl Psychiatry; 2015 Jun; 5(6):e586. PubMed ID: 26101849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CamK2A genetic variants with transition time from occasional to regular heroin use in a sample of heroin-dependent individuals.
    Eirich A; Biermann T; Müller CP; Kornhuber J; Benyamin B; Hulse GK; Wildenauer DB; Schwab SG
    Psychiatr Genet; 2019 Feb; 29(1):18-25. PubMed ID: 30260900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength.
    Barcomb K; Buard I; Coultrap SJ; Kulbe JR; O'Leary H; Benke TA; Bayer KU
    FASEB J; 2014 Aug; 28(8):3810-9. PubMed ID: 24843070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CAMKII in reinforcement learning: a computational model of glutamate and dopamine signaling pathways.
    Wanjerkhede SM; Bapi RS
    Biol Cybern; 2011 Jun; 104(6):397-424. PubMed ID: 21701878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl CpG binding protein 2 deficiency enhances expression of inflammatory cytokines by sustaining NF-κB signaling in myeloid derived cells.
    O'Driscoll CM; Lima MP; Kaufmann WE; Bressler JP
    J Neuroimmunol; 2015 Jun; 283():23-9. PubMed ID: 26004152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation.
    Wang SQ; Liu J; Qin J; Zhu Y; Tin VP; Yam JWP; Wong MP; Xiao ZJ
    Cell Death Dis; 2020 Jun; 11(6):410. PubMed ID: 32483123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactome Analyses implicated CAMK2A in the genetic predisposition and pharmacological mechanism of Bipolar Disorder.
    Li H; Zhou DS; Chang H; Wang L; Liu W; Dai SX; Zhang C; Cai J; Liu W; Li X; Fan W; Tang W; Tang W; Liu F; He Y; Bai Y; Hu Z; Xiao X; Gao L; Li M
    J Psychiatr Res; 2019 Aug; 115():165-175. PubMed ID: 31150948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.
    Murphy DM; Buckley PG; Das S; Watters KM; Bryan K; Stallings RL
    PLoS One; 2011; 6(6):e21436. PubMed ID: 21731748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a central Ca2+/calmodulin-dependent protein kinase IIalpha/beta binding domain in densin that selectively modulates glutamate receptor subunit phosphorylation.
    Jiao Y; Jalan-Sakrikar N; Robison AJ; Baucum AJ; Bass MA; Colbran RJ
    J Biol Chem; 2011 Jul; 286(28):24806-18. PubMed ID: 21610080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitation-transcription coupling via calcium/calmodulin-dependent protein kinase/ERK1/2 signaling mediates the coordinate induction of VGLUT2 and Narp triggered by a prolonged increase in glutamatergic synaptic activity.
    Doyle S; Pyndiah S; De Gois S; Erickson JD
    J Biol Chem; 2010 May; 285(19):14366-76. PubMed ID: 20212045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation and feedback regulation of metabotropic glutamate receptor 1 by calcium/calmodulin-dependent protein kinase II.
    Jin DZ; Guo ML; Xue B; Fibuch EE; Choe ES; Mao LM; Wang JQ
    J Neurosci; 2013 Feb; 33(8):3402-12. PubMed ID: 23426668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway.
    Yabuki Y; Wu L; Fukunaga K
    J Pharmacol Sci; 2019 Jul; 140(3):263-272. PubMed ID: 31474557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+/calmodulin-dependent protein kinase II inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors.
    Brooks IM; Tavalin SJ
    J Biol Chem; 2011 Feb; 286(8):6697-706. PubMed ID: 21156788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion.
    Yao ZH; Yao XL; Zhang Y; Zhang SF; Hu J
    Curr Neurovasc Res; 2017; 14(4):385-396. PubMed ID: 29090669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.